Summit Therapeutics Inc.SMMTNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-801.12M
↓ 487% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineContracting
Average
$-136.58M
Historical baseline
PeriodValueYoY Change
2025$-801.12M-276.4%
2024$-212.85M-206.5%
2023$-69.45M+5.0%
2022$-73.12M+14.9%
2021$-85.91M-69.6%
2020$-50.65M-138.6%
2019$-21.23M-282.2%
2018$11.65M+136.2%
2017$-32.19M-3.9%
2016$-30.98M-